
European Commission calls for reversal of Illumina's $7bn Grail merger
The commission on Monday sent a "statement of objections" outlining the process Illumina must follow in divesting Grail, its blood-testing...

INDUSTRIA BIOTEC 2023 with a broader perspective
At this year's INDUSTRIA BIOTEC – a European industry meeting that took place at the KINDL Centre for Contemporary Art in Berlin at the beginning of...

Bone Therapeutics merges with Medsenic and changes name
The combination of Medsenic and Bone Therapeutics will expand Bone Therapeutics' allogeneic cell therapy-based product portfolio in orthopedics...

C4X Discovery Holdings inks $402m deal with AstraZeneca
Under the agrrement, C4X Discovery Holdings plc (C4XD) will receive pre-clinical milestone payments worth up to $16m ahead of the first clinical...

BioNTech and Ryvu Therapeutics enter into global collaboration
BioNTech SE and Ryvu Therapeutics S.A. announced that the companies have entered into a multi-target research collaboration targeting immune...

Amsterdam Neogene Therapeutics aquired by AstraZeneca
Neogene Therapeutics is developing both patient-specific and shared neoantigen TCR programmes to deliver such TCRs into a patient's own T cells and...

First hints for leukopenia diagnostic in MS
Disease-modifying therapies for multiple sclerosis (MS) may positively influence the composition of the intestinal flora. At least this is what a...